Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
PepsiCo
PEP
$194B
| $77.3M | 0.04% |
454,662
+164,908
| +57% | +$28M |
|
377
Biogen
BIIB
$20.7B
| $77.2M | 0.04% |
398,136
+158,289
| +66% | +$30.7M |
|
378
Ameriprise Financial
AMP
$46.4B
| $76.8M | 0.04% |
163,477
+25,899
| +19% | +$12.2M |
|
|
XYZ
379
Block, Inc.
XYZ
$46.2B
| $76.2M | 0.04% |
1,135,089
-2,085,486
| -65% | -$140M |
|
380
Thermo Fisher Scientific
TMO
$184B
| $75.8M | 0.04% |
122,476
-442,945
| -78% | -$274M |
|
381
Edwards Lifesciences
EW
$47.1B
| $75.3M | 0.04% |
1,141,059
+616,852
| +118% | +$40.7M |
|
382
Altria Group
MO
$110B
| $75.2M | 0.04% |
1,474,323
+777,722
| +112% | +$39.7M |
|
383
AB InBev
BUD
$116B
| $75.2M | 0.04% |
1,133,661
+440,533
| +64% | +$29.2M |
|
384
Ascendis Pharma
ASND
$12.4B
| $74.9M | 0.04% |
501,690
+28,241
| +6% | +$4.22M |
|
385
EastGroup Properties
EGP
$8.91B
| $74.6M | 0.04% |
399,273
+210,937
| +112% | +$39.4M |
|
386
Extra Space Storage
EXR
$31.2B
| $74.6M | 0.04% |
413,865
-91,343
| -18% | -$16.5M |
|
387
Mondelez International
MDLZ
$80.1B
| $74.5M | 0.04% |
1,011,637
-588,963
| -37% | -$43.4M |
|
388
WESCO International
WCC
$10.6B
| $74.4M | 0.04% |
442,960
+90,260
| +26% | +$15.2M |
|
389
Welltower
WELL
$113B
| $74.3M | 0.04% |
580,651
-146,626
| -20% | -$18.8M |
|
390
Cheesecake Factory
CAKE
$2.99B
| $74.2M | 0.04% |
1,828,753
+623,459
| +52% | +$25.3M |
|
391
Vertex Pharmaceuticals
VRTX
$101B
| $74.1M | 0.04% |
159,294
+16,535
| +12% | +$7.69M |
|
392
IBM
IBM
$239B
| $73.4M | 0.03% |
332,123
+209,003
| +170% | +$46.2M |
|
393
Nucor
NUE
$33.1B
| $73.3M | 0.03% |
487,378
+146,559
| +43% | +$22M |
|
394
Verisk Analytics
VRSK
$38.1B
| $73M | 0.03% |
272,336
+99,531
| +58% | +$26.7M |
|
395
Jazz Pharmaceuticals
JAZZ
$7.88B
| $72.6M | 0.03% |
651,946
+201,074
| +45% | +$22.4M |
|
|
SGI
396
Somnigroup International Inc.
SGI
$18.1B
| $72.5M | 0.03% |
1,327,239
+1,042,801
| +367% | +$56.9M |
|
397
Wyndham Hotels & Resorts
WH
$6.71B
| $72.2M | 0.03% |
924,416
-249,988
| -21% | -$19.5M |
|
398
Humana
HUM
$37.3B
| $72.1M | 0.03% |
227,657
-328,279
| -59% | -$104M |
|
399
Dynatrace
DT
$15.1B
| $72.1M | 0.03% |
1,347,907
-540,203
| -29% | -$28.9M |
|
400
Alamos Gold
AGI
$13.8B
| $71.9M | 0.03% |
3,605,872
+790,345
| +28% | +$15.8M |
|